Economic evaluation of wheelchairs interventions: a systematic review

Imagem de Miniatura
Arquivos
art_FERRETTI_Economic_evaluation_of_wheelchairs_interventions_a_systematic_review_2023.PDF (2.18 MB)
Citações na Scopus
0
Tipo de produção
article
Data de publicação
2023
DOI
Scopus
Web of Science
PubMed
Título da Revista
ISSN da Revista
Título do Volume
Editora
TAYLOR & FRANCIS INC
Autores
FERRETTI, Eliana C.
COOPER, Rory A.
Citação
DISABILITY AND REHABILITATION-ASSISTIVE TECHNOLOGY, v.18, n.7, p.1163-1174, 2023
Projetos de Pesquisa
Unidades Organizacionais
Fascículo
Resumo
Objective: The overall aim of this systematic review was to identify and synthesise the best available evidence on effectiveness, resource use and costs involved in wheelchair interventions of adults with mobility limitations. Methodology: This systematic review was undertaken in accordance with the Centre for Reviews and Dissemination Guidelines. The protocol for this systematic review was registered with PROSPERO International Prospective Register of Systematic reviews. The following PICOS eligibility criteria were considered: (P) Population was individuals with mobility limitations that live in their community (e.g., non-institutionalized), with aged 18 or older; (I) Intervention was mobility assistive technologies (MAT), such as manual and powered wheelchairs; (C) Comparators (Not Applied); (O) Outcome, the primary outcome of interest, was established as the cost-effectiveness of wheelchair interventions. Direct and indirect costs per unit of effect were expressed in terms of clinical outcome units, quality-adjusted life years gained, utility scores, quality of life measures and incremental cost-effectiveness ratios to inform the economic outcomes. (S) Study design was considered as a health economic evaluation (i.e., including cost-effectiveness analysis, cost-utility analysis and cost benefit analysis as well as partial economic evaluations). The Consolidated Health Economic Evaluation Reporting Standards - CHEERS, checklist was used for summarising and interpreting the results of economic evaluations. Results: Sixteen studies were included, two were identified as full health economic evaluations and 14 were considered partial health economic evaluations. Conclusion: Only two full health economic analyses of wheelchair interventions have been conducted and both focussed on powered wheelchair provision. There are important gaps in current knowledge regarding wheelchair health economic methods and available outcome measures, which there is a great need for further research.
Palavras-chave
wheelchair, systematic review, assistive technology, cost effectiveness
URI
https://observatorio.fm.usp.br/handle/OPI/57495
Referências
  1. Andrich R, 1998, DISABIL REHABIL, V20, P1
  2. Andrich R, 2007, DISABIL REHABIL-ASSI, V2, P207, DOI 10.1080/17483100701325035
  3. [Anonymous], 1993, Health Status and Health Policy
  4. [Anonymous], 2011, WORLD REP DIS
  5. Ben Mortenson W, 2018, BMC GERIATR, V18, DOI 10.1186/s12877-018-0783-6
  6. Bray N, 2022, DISABIL REHABIL, V44, P2915, DOI 10.1080/09638288.2020.1844319
  7. Bray N, 2021, DISABIL REHABIL, V43, P3395, DOI 10.1080/09638288.2020.1741701
  8. Bray Nathan, 2017, BMC Res Notes, V10, P377, DOI 10.1186/s13104-017-2683-9
  9. Bray N, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0179269
  10. Bray Nathan, 2016, Pilot Feasibility Stud, V2, P32
  11. Bray N, 2014, BMC HEALTH SERV RES, V14, DOI 10.1186/1472-6963-14-309
  12. Brazier J, 2002, J HEALTH ECON, V21, P271, DOI 10.1016/S0167-6296(01)00130-8
  13. Briggs R., 2011, RADICALISATION ROLE
  14. Centre for Reviews and Dissemination, 2009, CRDS GUID UND REV HE
  15. Cooper RA, 1997, ARCH PHYS MED REHAB, V78, P1138, DOI 10.1016/S0003-9993(97)90141-6
  16. Cooper RA, 1999, ARCH PHYS MED REHAB, V80, P462, DOI 10.1016/S0003-9993(99)90287-3
  17. Cooper RA, 1996, J REHABIL RES DEV, V33, P45
  18. Cusick A, 2006, Pediatr Rehabil, V9, P149, DOI 10.1080/13638490500235581
  19. Davies A, 2003, DISABIL REHABIL, V25, P286, DOI 10.1080/0963828021000043734
  20. Day H., 1996, CAN J REHABIL, V9, P159, DOI 10.1080/09638280110066343
  21. Demers L., 2002, TECHNOLOGY DISABILIT, V14, P101, DOI [10.13072/midss.298, DOI 10.13072/MIDSS.298, DOI 10.3233/TAD-2002-14304]
  22. Fass MV, 2004, ARCH PHYS MED REHAB, V85, P805, DOI 10.1016/j.apmr.2003.08.096
  23. Fitzgerald SG, 2001, ARCH PHYS MED REHAB, V82, P1484, DOI 10.1053/apmr.2001.26139
  24. Gebrosky B, 2022, DISABIL REHABIL-ASSI, V17, P40, DOI 10.1080/17483107.2020.1754928
  25. Gebrosky B, 2020, DISABIL REHABIL-ASSI, V15, P432, DOI 10.1080/17483107.2019.1587018
  26. Gebrosky B, 2018, TOP SPINAL CORD INJ, V24, P63, DOI 10.1310/sci16-00057
  27. Gebrosky B, 2013, J REHABIL RES DEV, V50, P1373, DOI 10.1682/JRRD.2012.08.0155
  28. Gray DB, 2008, DISABIL REHABIL, V30, P434, DOI 10.1080/09638280701625377
  29. Gray DB, 2006, ARCH PHYS MED REHAB, V87, P189, DOI 10.1016/j.apmr.2005.09.014
  30. Hagberg L, 2017, DISABIL REHABIL-ASSI, V12, P115, DOI 10.3109/17483107.2014.1002540
  31. Hogaboom NS, 2018, ARCH PHYS MED REHAB, V99, P1949, DOI 10.1016/j.apmr.2018.04.002
  32. Hossain MS, 2019, SPINAL CORD, V57, P652, DOI 10.1038/s41393-019-0261-9
  33. Hubbard SL, 2007, J REHABIL RES DEV, V44, P581, DOI 10.1682/JRRD.2006.10.0136
  34. Husereau D, 2013, VALUE HEALTH, V16, P231, DOI 10.1016/j.jval.2013.02.002
  35. Hutter MF, 2014, EUR J HEALTH ECON, V15, P829, DOI 10.1007/s10198-013-0527-7
  36. Jacobs P, 2003, J DISABIL POLICY STU, V14, P120, DOI 10.1177/10442073030140021001
  37. Karimi M, 2016, PHARMACOECONOMICS, V34, P645, DOI 10.1007/s40273-016-0389-9
  38. Liu HY, 2008, J REHABIL RES DEV, V45, P1251, DOI 10.1682/JRRD.2007.12.0204
  39. Michel YA, 2016, HEALTH QUAL LIFE OUT, V14, DOI 10.1186/s12955-016-0565-9
  40. Mills T, 2002, DISABIL REHABIL, V24, P38, DOI 10.1080/09638280110066334
  41. Mortenson WB, 2007, DISABIL REHABIL-ASSI, V2, P275, DOI 10.1080/17483100701475863
  42. Mortenson WB, 2008, ARCH PHYS MED REHAB, V89, P1177, DOI 10.1016/j.apmr.2008.01.010
  43. Pearlman JL, 2005, ARCH PHYS MED REHAB, V86, P2361, DOI 10.1016/j.apmr.2005.07.294
  44. Pettersson I, 2007, ASSIST TECHNOL, V19, P143, DOI 10.1080/10400435.2007.10131871
  45. Phillips B, 1993, Assist Technol, V5, P36
  46. Rankin JW, 2012, CLIN BIOMECH, V27, P879, DOI 10.1016/j.clinbiomech.2012.07.002
  47. Ruggeri M, 2015, VALUE HEALTH, V18, P709, DOI 10.1016/j.jval.2015.03.1795
  48. Salatino C, 2016, ASSIST TECHNOL, V28, P41, DOI 10.1080/10400435.2015.1074631
  49. Salminen AL, 2009, J REHABIL MED, V41, P697, DOI 10.2340/16501977-0427
  50. Samuelsson K, 2014, DISABIL REHABIL-ASSI, V9, P330, DOI 10.3109/17483107.2013.827244
  51. Schraner I, 2008, DISABIL REHABIL, V30, P916, DOI 10.1080/09638280701800293
  52. Souza AE, 2013, J REHABIL RES DEV, V50, P1017, DOI 10.1682/JRRD.2011.03.0054
  53. Stanley RK, 2003, J REHABIL RES DEV, V40, P301, DOI 10.1682/JRRD.2003.07.0301
  54. Thielen FW, 2016, EXPERT REV PHARM OUT, V16, P705, DOI 10.1080/14737167.2016.1246962
  55. Toro ML, 2016, BMC HEALTH SERV RES, V16, DOI 10.1186/s12913-016-1268-y
  56. United Nations, 2006, CONV RIGHTS PERS DIS
  57. van Mastrigt GAPG, 2016, EXPERT REV PHARM OUT, V16, P689, DOI 10.1080/14737167.2016.1246960
  58. Wang H, 2010, DISABIL REHABIL-ASSI, V5, P318, DOI 10.3109/17483100903391137
  59. Whitehurst DGT, 2014, HEALTH QUAL LIFE OUT, V12, DOI 10.1186/1477-7525-12-50
  60. Wijnen BFM, 2016, EXPERT REV PHARM OUT, V16, P723, DOI 10.1080/14737167.2016.1246961
  61. WILLIAMS A, 1990, HEALTH POLICY, V16, P199
  62. World Health Organization, 2008, Guidelines on the provision of manual wheelchairs in less resourced settings
  63. World Health Organization, 2012, STUD ON GLOB AGEING

Coleções
Artigos e Materiais de Revistas Científicas - FM/MPR
Carregar mais